79952-0110 ZYNLONTA - CanMED: NDC

Product NDC:

79952-0110

Brand Name:

ZYNLONTA

Generic Name:

loncastuximab tesirine

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: LONCASTUXIMAB TESIRINE

Strength: 10.0

Unit: mg/2mL

Packages:

Code: 79952-0110-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Effective Date: April 30, 2021

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

CD19

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox